Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.380
+0.340 (11.18%)
Apr 29, 2026, 1:04 PM EDT - Market open
Cyclerion Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 14 | 5 | 8 | 8 | 29 | 75 | |
| Market Cap Growth | 119.17% | -40.69% | -0.51% | -71.30% | -61.69% | -28.31% | |
| Enterprise Value | 10 | 0 | 5 | -1 | 8 | 16 | |
| Last Close Price | 3.04 | 1.27 | 3.22 | 3.35 | 13.12 | 34.40 | |
| PS Ratio | 6.19 | 2.33 | 4.08 | - | 96.10 | 18.90 | |
| PB Ratio | 1.28 | 0.53 | 0.92 | 0.73 | 2.73 | 1.54 | |
| P/TBV Ratio | 1.41 | 0.53 | 0.92 | 0.73 | 2.73 | 1.54 | |
| EV/Sales Ratio | 4.63 | 0.13 | 2.64 | - | 27.39 | 3.93 | |
| Net Debt / Equity Ratio | -0.36 | -0.36 | -0.36 | -0.67 | -1.28 | -1.12 | |
| Net Debt / EBITDA Ratio | - | - | - | 0.79 | 0.72 | 1.00 | |
| Net Debt / FCF Ratio | 0.98 | 0.98 | 0.75 | 0.36 | 0.33 | 1.48 | |
| Asset Turnover | 0.21 | 0.21 | 0.17 | - | 0.01 | 0.05 | |
| Quick Ratio | 4.71 | 4.71 | 5.23 | 3.63 | 1.77 | 4.88 | |
| Current Ratio | 5.15 | 5.15 | 5.83 | 3.85 | 1.94 | 5.00 | |
| Return on Equity (ROE) | -39.34% | -39.34% | -30.36% | -115.85% | -62.17% | -95.87% | |
| Return on Assets (ROA) | -31.78% | -31.78% | -19.76% | -38.34% | -29.94% | -38.86% | |
| Return on Capital Employed (ROCE) | -54.70% | -54.70% | -41.00% | -85.50% | -177.40% | -112.60% | |
| Earnings Yield | -27.46% | -72.98% | -37.51% | -64.25% | -154.44% | -69.32% | |
| FCF Yield | -25.79% | -68.56% | -53.17% | -259.37% | -142.29% | -49.02% | |
| Buyback Yield / Dilution | -26.33% | -26.33% | -7.70% | -7.59% | -11.03% | -28.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.